文献速递糖尿病

血浆LRG1遗传变异与2型糖尿病患者肾功能快速下降相关

Association of Genetic Variants for Plasma LRG1 With Rapid Decline in Kidney Function in Patients With Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

在3694名2型糖尿病患者中开展全基因组关联研究,发现rs4806985变异与血浆LRG1水平强关联(meta P=6.66×10^-16)。在1337名肾功能保留的中国参与者中,该变异与肾功能快速下降风险升高相关(meta OR=1.23,P=0.030),孟德尔随机化分析提示血浆LRG1对肾功能下降可能存在因果效应。

要点

  • rs4806985变异与血浆LRG1水平强相关(meta P=6.66×10^-16)。
  • 该变异与肾功能快速下降风险升高相关(meta OR=1.23,P=0.030)。
  • 孟德尔随机化提示血浆LRG1对肾功能下降可能有因果效应。

核心结论

  • 遗传影响的血浆LRG1增加2型糖尿病患者肾功能快速下降风险,提示LRG1可能是潜在治疗靶点。

研究设计与样本

  • 在3694名2型糖尿病患者中开展血浆LRG1全基因组关联研究,包括新加坡发现队列1881人(983华人、420马来人、478印度人)和糖尿病肾病验证队列1813人(华人)。
  • 在1337名肾小球滤过功能保留(基线eGFR≥60 mL/min/1.73 m2)的中国2型糖尿病参与者中进行单样本孟德尔随机化分析。

主要发现

  • 鉴定出LRG1基因座附近的rs4806985变异与血浆LRG1水平稳健关联(meta P=6.66×10^-16)。
  • 在1337名参与者中,344人(26%)发生肾功能快速下降,rs4806985变异与肾功能快速下降风险升高相关(校正年龄和性别后meta OR=1.23,P=0.030)。
  • 孟德尔随机化分析为血浆LRG1对2型糖尿病患者肾功能下降的潜在因果效应提供了证据(P<0.05)。

关键数值与推荐

  • 肾功能快速下降定义为eGFR年下降≥3 mL/min/1.73 m2。

临床怎么用

  • 血浆LRG1及其遗传变异 rs4806985 可能有助于识别2型糖尿病中肾功能快速下降的高风险患者。
  • LRG1作为潜在治疗靶点,但需进一步研究阐明通路以指导糖尿病肾病预防。

局限性

  • 需进一步研究阐明潜在通路,为糖尿病肾病预防提供见解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Elevated levels of plasma leucine-rich α-2-glycoprotein 1 (LRG1), a component of transforming growth factor beta signaling, are associated with development and progression of chronic kidney disease in patients with type 2 diabetes (T2D). However, whether this relationship is causal is uncertain. OBJECTIVES: To identify genetic variants associated with plasma LRG1 levels and determine whether genetically predicted plasma LRG1 contributes to a rapid decline in kidney function (RDKF) in patients with T2D. DESIGN AND PARTICIPANTS: We performed a genome-wide association study of plasma LRG1 among 3694 T2D individuals [1881 (983 Chinese, 420 Malay, and 478 Indian) discovery from Singapore Study of Macro-angiopathy and Micro-vascular Reactivity in Type 2 Diabetes cohort and 1813 (Chinese) validation from Diabetic Nephropathy cohort]. One- sample Mendelian randomization analysis was performed among 1337 T2D Chinese participants with preserved glomerular filtration function [baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2)]. RDKF was defined as an eGFR decline of 3 mL/min/1.73 m2/year or greater. RESULTS: We identified rs4806985 variant near LRG1 locus robustly associated with plasma LRG1 levels (meta P = 6.66 × 10-16). Among 1337 participants, 344 (26%) developed RDKF, and the rs4806985 variant was associated with higher odds of RDKF (meta odds ratio = 1.23, P = 0.030 adjusted for age and sex). Mendelian randomization analysis provided evidence for a potential causal effect of plasma LRG1 on kidney function decline in T2D (P < 0.05). CONCLUSION: We demonstrate that genetically influenced plasma LRG1 increases the risk of RDKF in T2D patients, suggesting plasma LRG1 as a potential treatment target. However, further studies are warranted to elucidate underlying pathways to provide insight into diabetic kidney disease prevention.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Gurung RL, Dorajoo R, M Y, et al. Association of Genetic Variants for Plasma LRG1 With Rapid Decline in Kidney Function in Patients With Type 2 Diabetes. J Clin Endocrinol Metab. 2021. PMID: 33889958. doi:10.1210/clinem/dgab268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。